Literature DB >> 7775378

Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen.

K Inageda1, K Takahashi, K Tokita, H Nishina, Y Kanaho, I Kukimoto, K Kontani, S Hoshino, T Katada.   

Abstract

An ecto-enzyme of NAD glycohydrolase (NADase) induced by retinoic acid in HL-60 cells is attributed to the molecule of CD38 antigen [Kontani, K., Nishina, H., Ohoka, Y., Takahashi, K., and Katada, T. (1993) J. Biol. Chem. 268, 16895-16898]. CD38 antigen has an amino acid sequence homologous to Aplysia ADP-ribosyl cyclase which generates cyclic adenosine diphosphoribose (cADPR) and nicotinamide (NA) from beta-NAD+. On the basis of this sequence homology, we compared enzyme properties between CD38 NADase expressed as a fusion protein in Escherichia coli and ADP-ribosyl cyclase purified from the ovotestis of Aplysia kurodai. 1) beta-NAD+ analogs, nicotinamide 1, N6-ethenoadenine dinucleotide, and nicotinamide hypoxanthine dinucleotide, did not serve as good substrates for the ADP-ribosyl cyclase, suggesting that the intact adenine ring of beta-NAD+ was required for the cyclase-catalyzed reaction. On the other hand, CD38 NADase utilized the NAD analogs to form ADP-ribose and NA. 2) Kinetic analyses of the ADP-ribosyl cyclase reaction revealed that NA was first released from the substrate (beta-NAD+)-enzyme complex, followed by the release of another product, cADPR, which was capable of interacting with the free enzyme. 3) The enzyme reaction catalyzed by the ADP-ribosyl cyclase was fully reversible; beta-NAD+ could be formed from cADPR and NA with a velocity similar to that observed in the degradation of beta-NAD+. However, CD38 NADase did not catalyze the reverse reaction to form beta-NAD+ from ADP-ribopase and NA. 4) The CD38 NADase activity was, but the ADP-ribosyl cyclase activity was not, inhibited by dithiothreitol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775378     DOI: 10.1093/oxfordjournals.jbchem.a124698

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  14 in total

1.  Role of CD38, a cyclic ADP-ribosylcyclase, in morphine antinociception and tolerance.

Authors:  Lynn C Hull; Christopher Rabender; Bichoy H Gabra; Fan Zhang; Pin-Lan Li; William L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2010-06-15       Impact factor: 4.030

2.  Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157).

Authors:  A Sato; S Yamamoto; K Ishihara; T Hirano; H Jingami
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Identification of bovine liver mitochondrial NAD+ glycohydrolase as ADP-ribosyl cyclase.

Authors:  M Ziegler; D Jorcke; M Schweiger
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Effect of estrogen upon cyclic ADP ribose metabolism: beta-estradiol stimulates ADP ribosyl cyclase in rat uterus.

Authors:  E N Chini; F G de Toledo; M A Thompson; T P Dousa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

5.  Human CD38 is an authentic NAD(P)+ glycohydrolase.

Authors:  V Berthelier; J M Tixier; H Muller-Steffner; F Schuber; P Deterre
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

6.  Extracellular synthesis of cADP-ribose from nicotinamide-adenine dinucleotide by rat cortical astrocytes in culture.

Authors:  L Pawlikowska; S E Cottrell; M B Harms; Y Li; P A Rosenberg
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

7.  Nicotinamide inhibits cyclic ADP-ribose-mediated calcium signalling in sea urchin eggs.

Authors:  J K Sethi; R M Empson; A Galione
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

8.  Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases.

Authors:  C Cakir-Kiefer; H Muller-Steffner; F Schuber
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

9.  Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.

Authors:  Leman Yalçintepe; Emre Halis; Sibel Ulku
Journal:  Oncol Lett       Date:  2016-01-29       Impact factor: 2.967

10.  Initial Kinetic Characterization of Sterile Alpha and Toll/Interleukin Receptor Motif-Containing Protein 1.

Authors:  Heather S Loring; Janneke D Icso; Venkatesh V Nemmara; Paul R Thompson
Journal:  Biochemistry       Date:  2020-02-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.